John B. Thomas
Corporate Officer/Principal en NIRI NY Chapter .
Cargos activos de John B. Thomas
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NIRI NY Chapter | Corporate Officer/Principal | - | - |
Historial de carrera de John B. Thomas
Antiguos cargos conocidos de John B. Thomas.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Contacto de Relaciones con Inversores | 01/05/2015 | 01/01/2017 |
| ABBOTT LABORATORIES | Contacto de Relaciones con Inversores | 01/12/1995 | 01/05/2013 |
| Public Communications Contact | 01/12/1995 | 01/05/2013 | |
| Abbott Fund | Presidente | - | - |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Contacto de Relaciones con Inversores | 17/04/2018 | - |
| Public Communications Contact | 17/04/2018 | - | |
| University of Mississippi | Corporate Officer/Principal | - | - |
Formación de John B. Thomas.
| University of Mississippi | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Irlanda | 2 |
Operativa
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Empresas privadas | 4 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
| NIRI NY Chapter | |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Abbott Fund |
- Bolsa de valores
- Insiders
- John B. Thomas
- Experiencia
